Similar articles for PMID: 16418883

Year	Number of Results
1946	1
1950	1
1951	1
1960	1
1964	1
1980	1
1981	1
1982	1
1984	1
1985	3
1986	2
1988	1
1989	1
1990	2
1991	2
1992	2
1993	2
1996	1
1997	3
1998	3
1999	2
2000	4
2001	12
2002	11
2003	6
2004	15
2005	17
2006	23
2007	16
2008	23
2009	23
2010	23
2011	21
2012	17
2013	24
2014	14
2015	15
2016	12
2017	23
2018	13
2019	13
2020	10
2021	13
2022	20
2023	8
2024	0

1

[11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma.

Mann GN, Link JM, Pham P, Pickett CA, Byrd DR, Kinahan PE, Krohn KA, Mankoff DA. Mann GN, et al. Ann Surg Oncol. 2006 Feb;13(2):187-97. doi: 10.1245/ASO.2006.04.022. Epub 2006 Jan 19. Ann Surg Oncol. 2006. PMID: 16418883 Clinical Trial.

2

Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.

Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Eisenhofer G, King KS, Rao JU, Wesley RA, Adams KT, Pacak K. Timmers HJ, et al. J Natl Cancer Inst. 2012 May 2;104(9):700-8. doi: 10.1093/jnci/djs188. Epub 2012 Apr 18. J Natl Cancer Inst. 2012. PMID: 22517990 Free PMC article.

3

The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome.

Kaji P, Carrasquillo JA, Linehan WM, Chen CC, Eisenhofer G, Pinto PA, Lai EW, Pacak K. Kaji P, et al. Eur J Endocrinol. 2007 Apr;156(4):483-7. doi: 10.1530/EJE-06-0712. Eur J Endocrinol. 2007. PMID: 17389464

4

Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.

Timmers HJ, Kozupa A, Chen CC, Carrasquillo JA, Ling A, Eisenhofer G, Adams KT, Solis D, Lenders JW, Pacak K. Timmers HJ, et al. J Clin Oncol. 2007 Jun 1;25(16):2262-9. doi: 10.1200/JCO.2006.09.6297. J Clin Oncol. 2007. PMID: 17538171

5

PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma.

Shulkin BL, Wieland DM, Schwaiger M, Thompson NW, Francis IR, Haka MS, Rosenspire KC, Shapiro B, Sisson JC, Kuhl DE. Shulkin BL, et al. J Nucl Med. 1992 Jun;33(6):1125-31. J Nucl Med. 1992. PMID: 1597727 Free article.

6

Brown fat imaging with (18)F-6-fluorodopamine PET/CT, (18)F-FDG PET/CT, and (123)I-MIBG SPECT: a study of patients being evaluated for pheochromocytoma.

Hadi M, Chen CC, Whatley M, Pacak K, Carrasquillo JA. Hadi M, et al. J Nucl Med. 2007 Jul;48(7):1077-83. doi: 10.2967/jnumed.106.035915. Epub 2007 Jun 15. J Nucl Med. 2007. PMID: 17574980 Free article.

7

[Case of 131I-meta-iodobenzylguanidine (MIBG) scintigraphy-negative and 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET)-positive pheochromocytoma].

Jotoku M, Okura T, Nagao T, Enomoto D, Irita J, Miyoshi K, Kurata M, Fukuoka T, Higaki J. Jotoku M, et al. Nihon Jinzo Gakkai Shi. 2009;51(5):563-8. Nihon Jinzo Gakkai Shi. 2009. PMID: 19715165 Japanese.

8

6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.

Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR, Jager PL, Elsinga PH, Dierckx RA, van der Wal JE, Sluiter WJ, de Vries EG, Links TP. Fiebrich HB, et al. J Clin Endocrinol Metab. 2009 Oct;94(10):3922-30. doi: 10.1210/jc.2009-1054. Epub 2009 Jul 21. J Clin Endocrinol Metab. 2009. PMID: 19622618

9

6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.

Fottner C, Helisch A, Anlauf M, Rossmann H, Musholt TJ, Kreft A, Schadmand-Fischer S, Bartenstein P, Lackner KJ, Klöppel G, Schreckenberger M, Weber MM. Fottner C, et al. J Clin Endocrinol Metab. 2010 Jun;95(6):2800-10. doi: 10.1210/jc.2009-2352. Epub 2010 Apr 6. J Clin Endocrinol Metab. 2010. PMID: 20371665

10

Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.

Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Havekes B, Eisenhofer G, Martiniova L, Adams KT, Pacak K. Timmers HJ, et al. J Clin Endocrinol Metab. 2009 Dec;94(12):4757-67. doi: 10.1210/jc.2009-1248. Epub 2009 Oct 28. J Clin Endocrinol Metab. 2009. PMID: 19864450 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

373 results

Results by year